Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001720071 | SCV000519145 | likely benign | not provided | 2020-03-17 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000775657 | SCV000910050 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000874100 | SCV001016229 | likely benign | Peutz-Jeghers syndrome | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000775657 | SCV001178919 | likely benign | Hereditary cancer-predisposing syndrome | 2019-05-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003892130 | SCV004716418 | likely benign | STK11-related disorder | 2021-01-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV000874100 | SCV004818925 | likely benign | Peutz-Jeghers syndrome | 2023-10-30 | criteria provided, single submitter | clinical testing |